To further investigate whether EZH2 is essential for the suppression of LATS1, we performed a loss‐of‐function study by knockdown of LATS1 cells using siRNA in Caki‐1, ACHN, and UOK‐276 RCC cells (Fig. S3A). This evidence concerns the gene EZH2 and renal cell carcinoma.